Investor Overview

Investor Presentation
Financial News
May 16, 2019

Medicenna Therapeutics Corp. ("Medicenna" or "the Company") (TSX: MDNA, OTCQB: MDNAF), a clinical stage immuno-oncology company, today announced that Dr. Dina Randazzo of Duke University, will...

May 1, 2019

Medicenna Therapeutics Corp. ("Medicenna" or the "Company") (TSX: MDNA; OTCQB: MDNAF), a clinical stage immuno-oncology company, announced today that it has received US$757,940 (approximately,...

Stock Quote
TSXMDNA
Stock Chart
TSXMDNA
Upcoming Events
Sunday, June 2, 2019
8:00am - 11:00am EDT

Title: MDNA55: A Locally Administered IL4 Guided Toxin as a Targeted Treatment for Recurrent Glioblastoma Session Title: Central Nervous System Tumors Presenter: Dr. Dina Randazzo, DO, MS;...

Investor Contact
For more investor information, Please contact:
 
Elizabeth Williams, Chief Financial Officer
 
 
Email Alerts
* Required Fields